English Abstract
Journal Article
Add like
Add dislike
Add to saved papers

[SPECTRUM OF SPONTANEOUS PATHOLOGICAL CHANGES IN MOLE-VOLES AND THE EFFECT OF MITOCHONDRIA-TARGETED ANTIOXIDANT SkQ1 ON IT].

The mole vole (Ellobius talpinus (Pallas), Rodentia) is the object of interest for cytogenetics, ecology and gerontology research, peculiarly because of partial similarity of this animal to the unique long-living rodent, mole rat. In this work, the mole vole has been found to have very specific spectrum of tumors and non-tumor pathologies which vastly differs from pathological lesions spectrum in mole rat, laboratory mouse, rat and hamster. Mole voles had relatively small tumor incidence (9% totally in the observed population and 16% in animals dead after the achievement of the first tumor development age) and long minimal span of tumor latency (549 days) that is why this species could be categorized as cancer-resistant in compare to laboratory rodents (mice, rats, hamsters). The most common tumors in mole voles were hepatocellular neoplasms. Main non-tumor lesions were pneumonias and other septic and purulent diseases. Non-incapsulated, Gram-positive streptococci have been elucidated to be sole etiological agents in lesioned tissues. It is very important that septic and purulent diseases in mole voles commonly induced the neoplasia-like lesions (leukemoid reaction and "inflammatory pseudotumors"). Sex differences in pathological spectrum and incidences were not found. At last, it has been established that mitochondria-targeted antioxidant SkQ1 (which prolonged mole vole life span) did not significantly influence on spectrum and incidences of pathologies in mole voles.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app